A buffered form of creatine does not promote greater changes in muscle creatine content, body composition, or training adaptations than creatine monohydrate

Table 10 Serum lipids and glucose

Marker	N	Group	Day				p-level
			0	7	28
TCHL (mg/dl)	11	KA-L	149.1 ± 25	153.0 ± 23	149.9 ± 28	Group	0.91
	12	KA-H	153.3 ± 26	152.3 ± 28	157.5 ± 22	Time	0.15
	12	CrM	156.3 ± 20	147.3 ± 19	158.9 ± 21	G x T	0.10
HDL (mg/dl)	11	KA-L	48.8 ± 11.3	51.0 ± 9.3	52.9 ± 11.4	Group	0.42
	12	KA-H	53.0 ± 16.0	53.9 ± 18.4	53.6 ± 14.4	Time	0.03
	12	CrM	45.6 ± 6.5	47.6 ± 7.3	48.5 ± 8.4	G x T	0.64
TCHL: HDL Ratio	11	KA-L	3.16 ± 0.7	3.09 ± 0.6	2.92 ± 0.7	Group	0.34
	12	KA-H	3.03 ± 0.6	2.95 ± 0.5	3.04 ± 0.5	Time	0.04
	12	CrM	3.48 ± 0.6	3.15 ± 0.6	3.36 ± 0.7	G x T	0.09
LDL	11	KA-L	83.4 ± 16*	86.5 ± 16	81.4 ± 18*	Group	0.66
(mg/dl)	12	KA-H	79.4 ± 18*	82.7 ± 19	83.7 ± 16*	Time	0.42
	12	CrM	89.8 ± 20	81.4 ± 15†	92.5 ± 17	G x T	0.005
TRIG (mg/dl)	11	KA-L	84.5 ± 33	77.3 ± 30	78.5 ± 37	Group	0.20
	12	KA-H	105.1 ± 37	78.4 ± 26	101.1 ± 27	Time	0.07
	12	CrM	104.1 ± 28	92.1 ± 30	89.6 ± 30	G x T	0.45
Glucose (mg/dl)	11	KA-L	93.0 ± 5.1	90.5 ± 8.2	93.6 ± 4.7	Group	0.44
	12	KA-H	91.1 ± 6.6	92.7 ± 8.1	90.4 ± 6.9	Time	0.57
	12	CrM	90.5 ± 9.6	89.6 ± 5.5	88.3 ± 6.3	G x T	0.67

Values are means ± standard deviations. Lipid data were analyzed by MANOVA with repeated measures. Greenhouse-Geisser time and group x time (G x T) interaction p-levels are reported with univariate group p-levels. Glucose data were analyzed by repeated measures univariate ANOVA. † represents p < 0.05 difference from baseline. * represents p < 0.05 difference from CrM.

ISSN: 1550-2783